086040 — Biotoxtech Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩85bn
- KR₩111bn
- KR₩33bn
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,854 | 26,429 | 32,717 | 37,292 | 32,631 |
Cost of Revenue | |||||
Gross Profit | 5,370 | 6,436 | 10,546 | 12,480 | 1,899 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25,985 | 25,891 | 28,086 | 36,312 | 40,855 |
Operating Profit | -131 | 537 | 4,632 | 979 | -8,224 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,722 | 3,245 | 6,485 | -644 | -11,833 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,605 | 2,367 | 6,698 | 64.7 | -8,950 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,582 | 2,614 | 7,114 | 2,725 | -4,878 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1,582 | 2,614 | 7,114 | 2,725 | -4,878 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -103 | 180 | 446 | 82.9 | -314 |
Dividends per Share |